2026 NPPES data Hematology (Internal Medicine) Physician NPI 1225072648 MD
Verify on CMS →

DEVINDERPAL RANDHAWA, MD

Hematology (Internal Medicine) Physician in BUFFALO, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
277
Medicare Part D claims · 108 beneficiaries · Hematology (Internal Medicine) Physician avg: 693
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$831.91
22 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEVINDERPAL RANDHAWA, MD filed 277 Medicare Part D claims in 2023 as a Hematology (Internal Medicine) Physician in BUFFALO, New York, prescribing 86% generic.

277
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEVINDERPAL RANDHAWA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

277 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

DEVINDERPAL RANDHAWA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DEVINDERPAL RANDHAWA, MD?

Quality data not reported

NPI registry status

Active

Issued 06/15/2006

NPI 1225072648

Primary specialty

Hematology (Internal Medicine) Physician

Niche

1,436 US NPIs in this specialty

Medicare Part D claims

277 60% vs specialty avg

2023 prescription claims

Specialty avg: 693

Specialty distribution in New York

How Hematology (Internal Medicine) Physician compares to other specialties among New York providers

New York providers

Hematology (Internal Medicine) Physician share within New York

1. Hematology (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology (Internal Medicine) Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Hematology (Internal Medicine) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology (Internal Medicine) Physician ABMS/AOA estimate

Est. board-certified rate (Hematology (Internal Medicine) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology (Internal Medicine) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEVINDERPAL RANDHAWA, MD appears in the CMS NPPES registry as a Hematology (Internal Medicine) Physician provider holding MD credentials at 462 GRIDER ST, BUFFALO, NY, 14215, with a listed phone of (716) 898-5660. NPI 1225072648 was issued on 06/15/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RANDHAWA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 277 prescription claims written by this provider, covering 108 Medicare beneficiaries and totaling roughly $445K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 6.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology (Internal Medicine) Physician is a narrow specialty nationwide, with 1,436 enrolled providers across 50 states and an average of 693 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

462 GRIDER ST
BUFFALO, NY 14215

Provider Details

NPI 1225072648
Specialty Hematology (Internal Medicine) Physician
Credentials MD
Gender Male
NPI Issued 06/15/2006

Hospital and facility affiliations

Facilities where DEVINDERPAL RANDHAWA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ERIE COUNTY MEDICAL CENTER CORPORATION
BUFFALO, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEVINDERPAL RANDHAWA, MD. Source: openpaymentsdata.cms.gov.

Total received

$832

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DEVINDERPAL RANDHAWA, MD. To verify DEVINDERPAL RANDHAWA, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

DEVINDERPAL RANDHAWA, MD — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 277 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

277
Total Claims
$445K
Total Drug Cost
108
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
461
Total Day Supply
12,600
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$382K
Generic Drug Cost
$63K
Opioid Claims
19 (6.9% rate)

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.95
Gender Split
67% female / 33% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What DEVINDERPAL RANDHAWA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
24
Anastrozole
21
Dexamethasone
16
Prochlorperazine Maleate
16
Ibandronate Sodium
15
Ondansetron Odt
Ondansetron
12
Acyclovir
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology (Internal Medicine) Physician Overview

How DEVINDERPAL RANDHAWA, MD fits within the Hematology (Internal Medicine) Physician landscape nationally.

1,436
Hematology (Internal Medicine) Physician Providers in US
50
States with Hematology (Internal Medicine) Physician
693
Avg Claims per Provider

DEVINDERPAL RANDHAWA, MD's 277 claims are below the specialty average of 693.

Nearby Hematology (Internal Medicine) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as RANDHAWA.

Compare Hematology (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEVINDERPAL RANDHAWA, MD's specialty?
DEVINDERPAL RANDHAWA, MD specializes in Hematology (Internal Medicine) Physician and practices in BUFFALO, New York. Credentials: MD.
How much does DEVINDERPAL RANDHAWA, MD prescribe under Medicare Part D?
In 2023, DEVINDERPAL RANDHAWA, MD wrote 277 Medicare Part D claims totaling $445K in drug costs for 108 beneficiaries.
Where is DEVINDERPAL RANDHAWA, MD located?
DEVINDERPAL RANDHAWA, MD is located at 462 GRIDER ST, BUFFALO, NY, 14215. Phone: (716) 898-5660.
What is DEVINDERPAL RANDHAWA, MD's NPI number?
DEVINDERPAL RANDHAWA, MD's National Provider Identifier (NPI) is 1225072648, issued on 06/15/2006.
Does DEVINDERPAL RANDHAWA, MD prescribe more brand-name or generic drugs?
DEVINDERPAL RANDHAWA, MD's prescribing is 14% brand-name and 86% generic drugs by claim count, with $382K in brand drug costs.
Does DEVINDERPAL RANDHAWA, MD prescribe opioids?
Yes, DEVINDERPAL RANDHAWA, MD had 19 opioid claims in 2023 with an opioid prescribing rate of 6.9%.
How many Hematology (Internal Medicine) Physician providers are there in the US?
There are 1,436 Hematology (Internal Medicine) Physician providers across 50 states in the US. The average Hematology (Internal Medicine) Physician provider writes 693 Medicare Part D claims per year.
What drugs does DEVINDERPAL RANDHAWA, MD prescribe most often?
Based on 2023 Medicare Part D data, DEVINDERPAL RANDHAWA, MD's most frequently prescribed drugs include Letrozole, Anastrozole, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEVINDERPAL RANDHAWA, MD accept Medicare?
DEVINDERPAL RANDHAWA, MD appears in CMS Medicare data with 277 Part D claims and 108 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEVINDERPAL RANDHAWA, MD's credentials?
DEVINDERPAL RANDHAWA, MD's NPI is 1225072648 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology